Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Titanium Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel titanium-catalyzed process for high-purity statin intermediates. Delivers >99% ee and superior yields for reliable API manufacturing supply chains.
Patent CN110396100A reveals a novel nitrogen-oxygen ligand synthesis. Achieve high stereoselectivity and cost reduction in pharmaceutical intermediate manufacturing with scalable methods.
Patent CN110372544A reveals low-cost iron-titanium catalysis for biaryl synthesis. Achieve significant cost reduction and supply chain reliability in pharmaceutical intermediate manufacturing.
Patent CN115974770B reveals high-purity nitroxide synthesis. Enhanced stability and cost-effective manufacturing for global polymer additive supply chains.
Patent CN102731478A details a high-yield asymmetric oxidation route for Dexlansoprazole intermediates, offering superior optical purity and scalable manufacturing capabilities for global supply chains.
Patent CN104557867A reveals a high-purity Esomeprazole Sodium method. This report analyzes cost reduction and supply chain reliability for global buyers.
Patent CN104610226A reveals a novel asymmetric oxidation method for dexlansoprazole intermediates, offering high purity and scalable supply chain advantages for global pharmaceutical manufacturers.
Novel non-silylated route for Ezetimibe intermediates reduces cost and complexity. Ideal for reliable API intermediate supplier partnerships.
Patent CN101429192A details a novel chiral titanium catalysis method for high-purity proton pump inhibitor intermediates, offering significant supply chain and cost advantages.
Patent CN102977076A reveals a high-purity R-lansoprazole synthesis using chiral titanium catalysis. Discover cost-effective manufacturing insights for pharmaceutical supply chains.
Novel one-pot synthesis for benzodiazepine intermediates reduces costs and improves purity for midazolam and alprazolam manufacturing supply chains globally.
Patent CN114315532B reveals a high-yield titanium-catalyzed route for 1,4-tetraalkoxy-2-butene, offering significant cost reduction in carotenoid intermediate manufacturing.
Patent CN102603714B details a high-yield asymmetric oxidation method for PPI intermediates. Discover cost-effective manufacturing and supply chain advantages.
Patent CN102786533A discloses a novel reductive coupling method for [5] and [7] helicene analogs using solid phosgene, offering a scalable route for high-purity electronic chemical intermediates.
Patent CN102603716A details a novel titanium-catalyzed asymmetric oxidation for (S)-pantoprazole. Achieve 100% ee value with streamlined processing for reliable pharmaceutical intermediate supply.